MARIMarinomed Biotech AG
5.000EUR+11.11%Mkt Cap: 10.86M $P/E: 0.513d ago
Marinomed Biotech AG operates as a biopharmaceutical company in Austria, other European countries, and internationally. Its lead products include Budesolv for the treatment of allergic rhinitis in late-stage clinical dev…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap10.86M $
Enterprise Value20.53M $
Revenue (TTM)8.65M $
Gross Profit6.82M $
Net Income (TTM)19.59M $
Revenue/Share4.702 USD
Last Price5.000 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees32
CountryAT
SectorHealthcare
IndustryBiotechnology
ISINATMARINOMED6
Valuation
P/E (Trailing)0.51
P/E (Forward)1.97
PEG—
EV/EBITDA393.35
EV/Revenue2.37
P/S1.13
P/B-1.18
EPS (TTM)9.76
EPS (Forward)2.29
52W Range
2.20015% of range21.00
52W High21.00 EUR
52W Low2.200 EUR
Profitability
Gross Margin81.52%
Oper. Margin-427.74%
EBITDA Margin0.60%
Profit Margin234.27%
ROE-255.75%
ROA302.77%
Growth
Revenue Growth-76.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.20M $
CapEx (TTM)—
FCF Margin-23.98%
FCF Yield-19.09%
Net Debt11.53M $
Net Debt/EBITDA220.92
Balance Sheet
Debt/Equity-1.62
Current Ratio0.25
Quick Ratio0.22
Book Value/Sh-3.8290 EUR
Cash/Share0.5170 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.00M
Float1.37M
Insiders23.83%
Institutions14.49%
Technical
SMA 507.391 (-32.4%)
SMA 20014.01 (-64.3%)
Beta-0.23
S&P 52W Chg18.16%
Avg Vol (30d)2.10K
Avg Vol (10d)1.02K
Technical Indicators
RSI (14)41.2
MACD-0.7954
MACD Signal-0.9131
MACD Hist.+0.1177
BB Upper6.200 EUR
BB Middle5.215 EUR
BB Lower4.230 EUR
BB Width37.76%
ATR (14)0.4300 EUR
Vol Ratio (20d)0.78x